These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27007227)

  • 41. The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T cells in patients with leukemic cutaneous T-cell lymphoma.
    Shiue LH; Couturier J; Lewis DE; Wei C; Ni X; Duvic M
    Photodermatol Photoimmunol Photomed; 2015 Jul; 31(4):184-94. PubMed ID: 25772268
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circulating B-cell activating factor level predicts clinical response of chronic graft-versus-host disease to extracorporeal photopheresis.
    Whittle R; Taylor PC
    Blood; 2011 Dec; 118(24):6446-9. PubMed ID: 22021372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Updating ECP action mechanisms.
    Heshmati F
    Transfus Apher Sci; 2014 Jun; 50(3):330-9. PubMed ID: 24837416
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of a population-based cost-effectiveness model of chronic graft-versus-host disease in Spain.
    Crespo C; Pérez-Simón JA; Rodríguez JM; Sierra J; Brosa M
    Clin Ther; 2012 Aug; 34(8):1774-87. PubMed ID: 22835778
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extracorporeal photopheresis in 62 patients with acute and chronic GVHD: results of treatment with the COBE Spectra System.
    Hautmann AH; Wolff D; Hahn J; Edinger M; Schirmer N; Ammer J; Holler B; Landfried K; Hautmann MG; Ahrens N; Ugocsai P; Andreesen R; Holler E
    Bone Marrow Transplant; 2013 Mar; 48(3):439-45. PubMed ID: 22922407
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extracorporeal photochemotherapy in graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients.
    Perotti C; Del Fante C; Tinelli C; Viarengo G; Scudeller L; Zecca M; Locatelli F; Salvaneschi L
    Transfusion; 2010 Jun; 50(6):1359-69. PubMed ID: 20113452
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease.
    Flowers ME; Apperley JF; van Besien K; Elmaagacli A; Grigg A; Reddy V; Bacigalupo A; Kolb HJ; Bouzas L; Michallet M; Prince HM; Knobler R; Parenti D; Gallo J; Greinix HT
    Blood; 2008 Oct; 112(7):2667-74. PubMed ID: 18621929
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extracorporeal photopheresis with TC-V in Japanese patients with steroid-resistant chronic graft-versus-host disease.
    Okamoto S; Teshima T; Kosugi-Kanaya M; Kahata K; Kawashima N; Kato J; Mori T; Ozawa Y; Miyamura K
    Int J Hematol; 2018 Sep; 108(3):298-305. PubMed ID: 29959747
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Retrospective Multicenter Study of Extracorporeal Photopheresis in Steroid-Refractory Acute and Chronic Graft-versus-Host Disease.
    Oarbeascoa G; Lozano ML; Guerra LM; Amunarriz C; Saavedra CA; Garcia-Gala JM; Viejo A; Revilla N; Acosta Fleitas C; Arroyo JL; Martinez Revuelta E; Galego A; Hernandez-Maraver D; Kwon M; Diez-Martin JL; Pascual C;
    Biol Blood Marrow Transplant; 2020 Apr; 26(4):651-658. PubMed ID: 31917270
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD.
    Dignan FL; Greenblatt D; Cox M; Cavenagh J; Oakervee H; Apperley JF; Fielding AK; Pagliuca A; Mufti G; Raj K; Marks DI; Amrolia P; Peniket A; Medd P; Potter MN; Shaw BE; Scarisbrick JJ
    Bone Marrow Transplant; 2012 Jun; 47(6):824-30. PubMed ID: 21927038
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Successful implementation of a rural extracorporeal photopheresis program for the treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease in a rural hospital.
    Weber LL; Dunbar NM; Meehan KR; Szczepiorkowski ZM; Lansigan F
    J Clin Apher; 2015 Dec; 30(6):359-63. PubMed ID: 25691106
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Real-World Experience in Extracorporeal Photopheresis for Adults with Graft-versus-Host Disease.
    Asensi Cantó P; Sanz Caballer J; Sopeña Pell-Ilderton C; Solís Ruiz J; Lloret Madrid P; Villalba Montaner M; Facal Malvar A; Chorão P; Guerreiro M; Balaguer Roselló A; Montoro Gómez J; Santiago Balsera M; Solves Alcaína P; Sanz Alonso MÁ; De la Rubia Comos J; Gómez-Seguí I
    Transplant Cell Ther; 2023 Dec; 29(12):765.e1-765.e8. PubMed ID: 37703997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD).
    Child FJ; Ratnavel R; Watkins P; Samson D; Apperley J; Ball J; Taylor P; Russell-Jones R
    Bone Marrow Transplant; 1999 May; 23(9):881-7. PubMed ID: 10338042
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extracorporeal photopheresis as first-line strategy in the treatment of acute graft-versus-host disease after hematopoietic stem cell transplantation: A single-center experience.
    Sestili S; Eder S; Belhocine R; Dulery R; Battipaglia G; Brissot E; Mediavilla C; Banet A; van de Wyngaert Z; Paviglianiti A; Ledraa T; Bonin A; Mohty M; Malard F
    Cytotherapy; 2020 Aug; 22(8):445-449. PubMed ID: 32434750
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extracorporeal photochemotherapy.
    Maeda A
    J Dermatol Sci; 2009 Jun; 54(3):150-6. PubMed ID: 19369039
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in children and adolescents.
    Buder K; Zirngibl M; Bapistella S; Meerpohl JJ; Strahm B; Bassler D; Weitz M
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD009898. PubMed ID: 35679154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role for CD4(+)CD25(+) T cells in inhibition of graft rejection by extracorporeal photopheresis.
    George JF; Gooden CW; Guo L; Kirklin JK
    J Heart Lung Transplant; 2008 Jun; 27(6):616-22. PubMed ID: 18503960
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Extracorporeal photopheresis in the treatment of patients with refractory chronic graft-versus-host disease after allogeneic bone marrow transplantation].
    Bykova TA; Kozlov AV; Stancheva NV; Semënova EV; Kulagina II; Bondarenko SN; Vavilov VN; Morozova EV; Zubarovskaia LS; Afanas'ev BV
    Ter Arkh; 2013; 85(8):60-8. PubMed ID: 24137966
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The assessment of immune-regulatory effects of extracorporeal photopheresis in systemic sclerosis: a long-term follow-up study.
    Papp G; Horvath IF; Gyimesi E; Barath S; Vegh J; Szodoray P; Zeher M
    Immunol Res; 2016 Apr; 64(2):404-11. PubMed ID: 26168768
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Single centre retrospective analysis of extracorporeal photopheresis (ECP) therapy in patients heavily pre-treated for chronic graft-versus-host disease (cGvHD) with steroid failure.
    Linn SM; Novitzky-Basso I; Patriquin C; Pasic I; Lam W; Law A; Michelis FV; Gerbitz A; Viswabandya A; Lipton J; Kumar R; Mattsson J; Barth D; Kim DDH
    Leuk Res; 2023 Nov; 134():107387. PubMed ID: 37734221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.